CareLit · DOI-Nachweis · Pneumologie
Canopy-2: Phase 3 Study of Canakinumab plus Docetaxel as Second/Third Line Therapy in Locally Advanced/Metastatic NSCLC
DOI 10.1055/s-0039-3403092
Bibliografische Angaben
Nachweis in CareLit
Autor:innenM Reck, L Paz-Ares, Y Goto, D Lim, VA Papadimitrakopoulou, B Mookerjee, I Malet, Z Zewen
ZeitschriftPneumologie
AusgabeS 01 S 01/2020
Jahrgang / SeitenJg. 74
Kernaussage aus der Literatur
Abstract-Vorschau
Canopy-2: Phase 3 Study of Canakinumab plus Docetaxel as Second/Third Line Therapy in Locally Advanced/Metastatic NSCLC
Zitieren
Zitierempfehlung
M Reck, L Paz-Ares, Y Goto, D Lim, VA Papadimitrakopoulou, B Mookerjee, I Malet, Z Zewen (2020) Canopy-2: Phase 3 Study of Canakinumab plus Docetaxel as Second/Third Line Therapy in Locally Advanced/Metastatic NSCLC. Pneumologie, 74 (S 01 S 01). https://doi.org/10.1055/s-0039-3403092
Mit CareLit weiterarbeiten